2022 Full Year Results

Bekaert delivers strong sales growth and robust financial results in challenging market conditions
Sales up +17% • EBITu of € 459 million (margin 8.1%) • Net debt/EBITDAu of 0.7x • Proposed dividend of € 1.65 per share and continued share buyback

Bekaert achieved strong sales growth responding quickly to the challenges of high raw material and energy cost inflation with product price rises. These swift actions, along with further operational efficiencies, helped to protect profitability despite higher input costs and lower utilization. These results also reflect the successful execution of Bekaert’s strategy, where the core businesses have been further strengthened, whilst also repositioning to target new markets with opportunities from energy transition and decarbonization trends.

Financial Highlights

Operational and strategic highlights

Committed to return value to our shareholders

The Board of Directors seeks to maintain a prudent approach to capital allocation, balancing investment in future growth, maintenance of a strong balance sheet and shareholders’ returns. The successful execution of the strategic plan and robust financial performance have strengthened Bekaert’s balance sheet position and overall cash generation through time, and therefore potential returns to shareholders. In 2022, the dividend was increased by 50% and a share buyback program of up to € 120 million was commenced, executed over four equal tranches and completed in February 2023.

Against this robust financial position and the policy set out above, the Group intends to take a balanced approach with the following returns:

As before, the purpose of the program will be to reduce the issued share capital of the company and shares repurchased will be cancelled.

Outlook

Whilst trading in 2023 has started well across all business units, economic uncertainties remain. The robust performance delivered in 2022 and the company’s strong financial position, gives us confidence in our ability to deliver further on our strategic priorities. We therefore continue to confirm our ambition to reach the mid-term targets (2022-2026) of organic sales growth of 3%+ CAGR and an underlying EBIT margin level of 9% to 11% through the cycle. 

 

Attachment